Appetite-regulating hormones—leptin, adiponectin and ghrelin—and the development of prostate cancer: a systematic review and exploratory meta-analysis
Prostate Cancer and Prostatic Diseases, Published online: 30 May 2019; doi:10.1038/s41391-019-0154-1Appetite-regulating hormones—leptin, adiponectin and ghrelin—and the development of prostate cancer: a systematic review and exploratory meta-analysis (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - May 30, 2019 Category: Urology & Nephrology Authors: Charlotte Zoe Angel Isabel Iguacel Amy Mullee Neela Guha Rachel Wasson Declan J. McKenna Marc J. Gunter Vitaly Smelov Inge Huybrechts Source Type: research

Performance of [68Ga] Ga-PSMA 11 PET for detecting prostate cancer in the lymph nodes before salvage lymph node dissection: a systematic review and meta-analysis
Prostate Cancer and Prostatic Diseases, Published online: 30 May 2019; doi:10.1038/s41391-019-0156-zPerformance of [68Ga] Ga-PSMA 11 PET for detecting prostate cancer in the lymph nodes before salvage lymph node dissection: a systematic review and meta-analysis (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - May 30, 2019 Category: Urology & Nephrology Authors: Shoji Kimura Mohammad Abufaraj Florian Janisch Takehiro Iwata Mehdi Kardoust Parizi Beat Foerster Nicola Fossati Alberto Briganti Shin Egawa Markus Hartenbach Shahrokh F. Shariat Source Type: research

Androgen decline and survival during docetaxel therapy in metastatic castration resistant prostate cancer (mCRPC)
Androgen decline and survival during docetaxel therapy in metastatic castration resistant prostate cancer (mCRPC), Published online: 03 May 2019; doi:10.1038/s41391-019-0152-3Androgen decline and survival during docetaxel therapy in metastatic castration resistant prostate cancer (mCRPC) (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - May 3, 2019 Category: Urology & Nephrology Authors: Charles J. Ryan Sandipan Dutta William K. Kelly Carly Russell Eric J. Small Michael J. Morris Mary-Ellen Taplin Susan Halabi Source Type: research

Characterization of a KLK2-FGFR2 fusion gene in two cases of metastatic prostate cancer
Characterization of a KLK2-FGFR2 fusion gene in two cases of metastatic prostate cancer, Published online: 01 May 2019; doi:10.1038/s41391-019-0145-2Characterization of a KLK2-FGFR2 fusion gene in two cases of metastatic prostate cancer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - May 1, 2019 Category: Urology & Nephrology Authors: Melanie A. Krook Hannah Barker Hui-Zi Chen Julie W. Reeser Michele R. Wing Dorrelyn Martin Amy M. Smith Thuy Dao Russell Bonneville Eric Samorodnitsky Jharna Miya Aharon G. Freud J. Paul Monk Steven K. Clinton Sameek Roychowdhury Source Type: research

Measuring the unmeasurable: automated bone scan index as a quantitative endpoint in prostate cancer clinical trials
Measuring the unmeasurable: automated bone scan index as a quantitative endpoint in prostate cancer clinical trials, Published online: 29 April 2019; doi:10.1038/s41391-019-0151-4Measuring the unmeasurable: automated bone scan index as a quantitative endpoint in prostate cancer clinical trials (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - April 29, 2019 Category: Urology & Nephrology Authors: Jose Mauricio Mota Andrew J. Armstrong Steven M. Larson Josef J. Fox Michael J. Morris Source Type: research

Validity of the National Death Index to ascertain the date and cause of death in men having undergone prostatectomy for prostate cancer
Validity of the National Death Index to ascertain the date and cause of death in men having undergone prostatectomy for prostate cancer, Published online: 29 April 2019; doi:10.1038/s41391-019-0146-1Validity of the National Death Index to ascertain the date and cause of death in men having undergone prostatectomy for prostate cancer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - April 29, 2019 Category: Urology & Nephrology Authors: Drew Moghanaki Lauren E. Howard Amanda De Hoedt William J. Aronson Christopher J. Kane Christopher L. Amling Matthew R. Cooperberg Martha K. Terris Stephen J. Freedland Source Type: research

Assessing the relationship between statin use and oncologic outcomes among men electing active surveillance for localized prostate cancer
Assessing the relationship between statin use and oncologic outcomes among men electing active surveillance for localized prostate cancer, Published online: 17 April 2019; doi:10.1038/s41391-019-0147-0Assessing the relationship between statin use and oncologic outcomes among men electing active surveillance for localized prostate cancer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - April 17, 2019 Category: Urology & Nephrology Authors: Yaw A. Nyame Lamont Wilkins Daniel J. Greene Vishnu Ganesan Charles Dai Nima Almassi Andrew J. Stephenson Michael Gong Ryan Berglund Eric A. Klein Source Type: research

A predictive model based on biparametric magnetic resonance imaging and clinical parameters for improved risk assessment and selection of biopsy-naïve men for prostate biopsies
A predictive model based on biparametric magnetic resonance imaging and clinical parameters for improved risk assessment and selection of biopsy-naïve men for prostate biopsiesA predictive model based on biparametric magnetic resonance imaging and clinical parameters for improved risk assessment and selection of biopsy-naïve men for prostate biopsies, Published online: 15 April 2019; doi:10.1038/s41391-019-0149-yA predictive model based on biparametric magnetic resonance imaging and clinical parameters for improved risk assessment and selection of biopsy-naïve men for prostate biopsies (Source: Prostate Canc...
Source: Prostate Cancer and Prostatic Diseases - April 15, 2019 Category: Urology & Nephrology Authors: Lars Boesen Frederik B. Thomsen Nis N ørgaard Vibeke L øgager Ingegerd Balslev Rasmus Bisbjerg Henrik S. Thomsen Henrik Jakobsen Source Type: research

Stroke and thromboembolic events in men with prostate cancer treated with definitive radiation therapy with or without androgen deprivation therapy
Stroke and thromboembolic events in men with prostate cancer treated with definitive radiation therapy with or without androgen deprivation therapy, Published online: 15 April 2019; doi:10.1038/s41391-019-0150-5Stroke and thromboembolic events in men with prostate cancer treated with definitive radiation therapy with or without androgen deprivation therapy (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - April 15, 2019 Category: Urology & Nephrology Authors: Rishi Deka Daniel R. Simpson Matthew S. Panizzon Richard L. Hauger Paul Riviere Vinit Nalawade Rana McKay James D. Murphy Brent S. Rose Source Type: research

Letter to the Editor: “Characterizing the learning curve of the MRI–US fusion prostate biopsies”
Letter to the Editor: “Characterizing the learning curve of the MRI–US fusion prostate biopsies”Letter to the Editor: “Characterizing the learning curve of the MRI–US fusion prostate biopsies”, Published online: 15 April 2019; doi:10.1038/s41391-019-0148-zLetter to the Editor: “Characterizing the learning curve of the MRI–US fusion prostate biopsies” (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - April 15, 2019 Category: Urology & Nephrology Authors: Epaminondas Markos Valsamis Source Type: research

Prostate cancer in the medicare shared savings program: are Accountable Care Organizations associated with reduced expenditures for men with prostate cancer?
Prostate cancer in the medicare shared savings program: are Accountable Care Organizations associated with reduced expenditures for men with prostate cancer?, Published online: 12 April 2019; doi:10.1038/s41391-019-0138-1Prostate cancer in the medicare shared savings program: are Accountable Care Organizations associated with reduced expenditures for men with prostate cancer? (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - April 12, 2019 Category: Urology & Nephrology Authors: Alexander P. Cole Anna Krasnova Ashwin Ramaswamy David F. Friedlander Sean A. Fletcher Maxine Sun Toni K. Choueiri Joel S. Weissman Adam S. Kibel Quoc-Dien Trinh Source Type: research

Prolonged PSA stabilization and overall survival following sipuleucel-T monotherapy in metastatic castration-resistant prostate cancer patients
Prolonged PSA stabilization and overall survival following sipuleucel-T monotherapy in metastatic castration-resistant prostate cancer patients, Published online: 12 April 2019; doi:10.1038/s41391-019-0144-3Prolonged PSA stabilization and overall survival following sipuleucel-T monotherapy in metastatic castration-resistant prostate cancer patients (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - April 12, 2019 Category: Urology & Nephrology Authors: Eda K. Holl Megan A. McNamara Patrick Healy Monika Anand Raoul S. Concepcion Coleman D. Breland Igor Dumbudze Ron Tutrone Neal Shore Andrew J. Armstrong Michael Harrison Joe A. Wallace Yuan Wu Daniel J. George Source Type: research

Dietary inflammatory index (DII) and risk of prostate cancer in a case–control study among Black and White US Veteran men
Dietary inflammatory index (DII) and risk of prostate cancer in a case–control study among Black and White US Veteran menDietary inflammatory index (DII) and risk of prostate cancer in a case–control study among Black and White US Veteran men, Published online: 12 April 2019; doi:10.1038/s41391-019-0143-4Dietary inflammatory index (DII) and risk of prostate cancer in a case–control study among Black and White US Veteran men (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - April 12, 2019 Category: Urology & Nephrology Authors: Adriana C. Vidal Taofik Oyekunle Lauren E. Howard Nitin Shivappa Amanda De Hoedt Jane C. Figueiredo Emanuela Taioli Jay H. Fowke Pao-Hwa Lin James R. Hebert Stephen J. Freedland Source Type: research

Proton versus photon-based radiation therapy for prostate cancer: emerging evidence and considerations in the era of value-based cancer care
Proton versus photon-based radiation therapy for prostate cancer: emerging evidence and considerations in the era of value-based cancer care, Published online: 09 April 2019; doi:10.1038/s41391-019-0140-7Proton versus photon-based radiation therapy for prostate cancer: emerging evidence and considerations in the era of value-based cancer care (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - April 9, 2019 Category: Urology & Nephrology Authors: Sophia C. Kamran Jay O. Light Jason A. Efstathiou Source Type: research

Anti-metastatic effect of ranolazine in an in vivo rat model of prostate cancer, and expression of voltage-gated sodium channel protein in human prostate
Anti-metastatic effect of ranolazine in an in vivo rat model of prostate cancer, and expression of voltage-gated sodium channel protein in human prostate, Published online: 20 March 2019; doi:10.1038/s41391-019-0128-3Anti-metastatic effect of ranolazine in an in vivo rat model of prostate cancer, and expression of voltage-gated sodium channel protein in human prostate (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - March 20, 2019 Category: Urology & Nephrology Authors: Ilknur Bugan Selma Kucuk Zeynep Karagoz Scott P. Fraser Handan Kaya Andrew Dodson Christopher S. Foster Seyhan Altun Mustafa B. A. Djamgoz Source Type: research

Association of prostate cancer SLCO gene expression with Gleason grade and alterations following androgen deprivation therapy
Association of prostate cancer SLCO gene expression with Gleason grade and alterations following androgen deprivation therapy, Published online: 19 March 2019; doi:10.1038/s41391-019-0141-6Association of prostate cancer SLCO gene expression with Gleason grade and alterations following androgen deprivation therapy (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - March 19, 2019 Category: Urology & Nephrology Authors: Mazen Alsinnawi Ailin Zhang Daniella Bianchi-Frias John Burns Eunpi Cho Xiaotun Zhang Adam Sowalsky Huihui Ye April E. Slee Lawrence True Christopher Porter Mary-Ellen Taplin Steven Balk Peter S. Nelson R. Bruce Montgomery Elahe A. Mostaghel Source Type: research

Adiponectin: the “unusual suspect” between insulin resistance and cancer?
Adiponectin: the “unusual suspect” between insulin resistance and cancer?Adiponectin: the “unusual suspect” between insulin resistance and cancer?, Published online: 11 March 2019; doi:10.1038/s41391-019-0142-5Adiponectin: the “unusual suspect” between insulin resistance and cancer? (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - March 11, 2019 Category: Urology & Nephrology Authors: Konstantinos Michalakis Source Type: research

SPINK1 expression is enriched in African American prostate cancer but is not associated with altered immune infiltration or oncologic outcomes post-prostatectomy
SPINK1 expression is enriched in African American prostate cancer but is not associated with altered immune infiltration or oncologic outcomes post-prostatectomy, Published online: 08 March 2019; doi:10.1038/s41391-019-0139-0SPINK1 expression is enriched in African American prostate cancer but is not associated with altered immune infiltration or oncologic outcomes post-prostatectomy (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - March 8, 2019 Category: Urology & Nephrology Authors: Farzana A. Faisal Harsimar B. Kaur Jeffrey J. Tosoian Scott A. Tomlins Edward M. Schaeffer Tamara L. Lotan Source Type: research

Characterizing the learning curve of MRI-US fusion prostate biopsies
Characterizing the learning curve of MRI-US fusion prostate biopsies, Published online: 06 March 2019; doi:10.1038/s41391-019-0137-2Characterizing the learning curve of MRI-US fusion prostate biopsies (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - March 6, 2019 Category: Urology & Nephrology Authors: Daniel Halstuch Jack Baniel David Lifshitz Sivan Sela Yaara Ber David Margel Source Type: research

Efficacy and safety of enucleation vs. resection of prostate for treatment of benign prostatic hyperplasia: a meta-analysis of randomized controlled trials
Efficacy and safety of enucleation vs. resection of prostate for treatment of benign prostatic hyperplasia: a meta-analysis of randomized controlled trials, Published online: 28 February 2019; doi:10.1038/s41391-019-0135-4Efficacy and safety of enucleation vs. resection of prostate for treatment of benign prostatic hyperplasia: a meta-analysis of randomized controlled trials (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - February 28, 2019 Category: Urology & Nephrology Authors: Yucong Zhang Penghui Yuan Delin Ma Xintao Gao Chao Wei Zhuo Liu Rui Li Shaogang Wang Jihong Liu Xiaming Liu Source Type: research

Prediction of extraprostatic extension by MRI tumor contact length: difference between anterior and posterior prostate cancer
Prediction of extraprostatic extension by MRI tumor contact length: difference between anterior and posterior prostate cancer, Published online: 27 February 2019; doi:10.1038/s41391-019-0136-3Prediction of extraprostatic extension by MRI tumor contact length: difference between anterior and posterior prostate cancer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - February 27, 2019 Category: Urology & Nephrology Authors: Kazuhiro Matsumoto Hirotaka Akita Keiichi Narita Akinori Hashiguchi Kimiharu Takamatsu Toshikazu Takeda Takeo Kosaka Ryuichi Mizuno Eiji Kikuchi Mototsugu Oya Masahiro Jinzaki Source Type: research

MEK-ERK signaling is a therapeutic target in metastatic castration resistant prostate cancer
MEK-ERK signaling is a therapeutic target in metastatic castration resistant prostate cancer, Published online: 25 February 2019; doi:10.1038/s41391-019-0134-5MEK-ERK signaling is a therapeutic target in metastatic castration resistant prostate cancer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - February 25, 2019 Category: Urology & Nephrology Authors: Nicholas G. Nickols Ramin Nazarian Shuang G. Zhao Victor Tan Vladislav Uzunangelov Zheng Xia Robert Baertsch Elad Neeman Allen C. Gao George V. Thomas Lauren Howard Amanda M. De Hoedt Josh Stuart Theodore Goldstein Kim Chi Martin E. Gleave Julie N. Graff Source Type: research

Correction: Metabolic syndrome increases the risk of upgrading and upstaging in patients with prostate cancer on biopsy: a radical prostatectomy multicenter cohort study
Correction: Metabolic syndrome increases the risk of upgrading and upstaging in patients with prostate cancer on biopsy: a radical prostatectomy multicenter cohort study, Published online: 01 February 2019; doi:10.1038/s41391-019-0132-7Correction: Metabolic syndrome increases the risk of upgrading and upstaging in patients with prostate cancer on biopsy: a radical prostatectomy multicenter cohort study (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - February 1, 2019 Category: Urology & Nephrology Authors: Cosimo De Nunzio Aldo Brassetti Giuseppe Simone Riccardo Lombardo Riccardo Mastroianni Devis Collura Giovanni Muto Michele Gallucci Andrea Tubaro Source Type: research

Correction: Predictors of fluoroquinolone-resistant bacteria in the rectal vault of men undergoing prostate biopsy
Correction: Predictors of fluoroquinolone-resistant bacteria in the rectal vault of men undergoing prostate biopsy, Published online: 31 January 2019; doi:10.1038/s41391-019-0133-6Correction: Predictors of fluoroquinolone-resistant bacteria in the rectal vault of men undergoing prostate biopsy (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - January 31, 2019 Category: Urology & Nephrology Authors: Wei Phin Tan Dimitri Papagiannopoulos Kalyan C. Latchamsetty Nathaniel Wilson Nicholas O ’Block Lester Raff Alfredo Mena Lora Christopher L. Coogan Michael R. Abern Source Type: research

Allopurinol and the risk of prostate cancer in a Finnish population-based cohort
Allopurinol and the risk of prostate cancer in a Finnish population-based cohort, Published online: 29 January 2019; doi:10.1038/s41391-019-0129-2Allopurinol and the risk of prostate cancer in a Finnish population-based cohort (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - January 29, 2019 Category: Urology & Nephrology Authors: Ville Kukko Antti Kaipia Kirsi Talala Kimmo Taari Teuvo L. J. Tammela Anssi Auvinen Teemu J. Murtola Source Type: research

Androgen deprivation therapy for prostate cancer and the risk of autoimmune diseases
Androgen deprivation therapy for prostate cancer and the risk of autoimmune diseases, Published online: 28 January 2019; doi:10.1038/s41391-019-0130-9Androgen deprivation therapy for prostate cancer and the risk of autoimmune diseases (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - January 28, 2019 Category: Urology & Nephrology Authors: Jui-Ming Liu Cheng-Ping Yu Heng-Chang Chuang Chun-Te Wu Ren-Jun Hsu Source Type: research

Total nut, tree nut, peanut, and peanut butter intake and the risk of prostate cancer in the Netherlands Cohort Study
Total nut, tree nut, peanut, and peanut butter intake and the risk of prostate cancer in the Netherlands Cohort Study, Published online: 28 January 2019; doi:10.1038/s41391-019-0131-8Total nut, tree nut, peanut, and peanut butter intake and the risk of prostate cancer in the Netherlands Cohort Study (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - January 28, 2019 Category: Urology & Nephrology Authors: Esther A. Boudewijns Lisette Nieuwenhuis Milan S. Geybels Piet A. van den Brandt Source Type: research

Blood glucose, glucose balance, and disease-specific survival after prostate cancer diagnosis in the Finnish Randomized Study of Screening for Prostate Cancer
Blood glucose, glucose balance, and disease-specific survival after prostate cancer diagnosis in the Finnish Randomized Study of Screening for Prostate Cancer, Published online: 24 January 2019; doi:10.1038/s41391-018-0123-0Blood glucose, glucose balance, and disease-specific survival after prostate cancer diagnosis in the Finnish Randomized Study of Screening for Prostate Cancer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - January 24, 2019 Category: Urology & Nephrology Authors: Teemu J. Murtola Samueli M. S älli Kirsi Talala Kimmo Taari Teuvo L. J. Tammela Anssi Auvinen Source Type: research

Utility after robot-assisted radical prostatectomy compared to conventional approaches for localized prostate cancer [socioeconomic perspective study]
Utility after robot-assisted radical prostatectomy compared to conventional approaches for localized prostate cancer [socioeconomic perspective study], Published online: 24 January 2019; doi:10.1038/s41391-018-0119-9Utility after robot-assisted radical prostatectomy compared to conventional approaches for localized prostate cancer [socioeconomic perspective study] (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - January 24, 2019 Category: Urology & Nephrology Authors: Min-Jin Lee Dong-Ah Park Seon Heui Lee Source Type: research

A lifestyle intervention of weight loss via a low-carbohydrate diet plus walking to reduce metabolic disturbances caused by androgen deprivation therapy among prostate cancer patients: carbohydrate and prostate study 1 (CAPS1) randomized controlled trial
A lifestyle intervention of weight loss via a low-carbohydrate diet plus walking to reduce metabolic disturbances caused by androgen deprivation therapy among prostate cancer patients: carbohydrate and prostate study 1 (CAPS1) randomized controlled trialA lifestyle intervention of weight loss via a low-carbohydrate diet plus walking to reduce metabolic disturbances caused by androgen deprivation therapy among prostate cancer patients: carbohydrate and prostate study 1 (CAPS1) randomized controlled trial, Published online: 21 January 2019; doi:10.1038/s41391-019-0126-5A lifestyle intervention of weight loss via a ...
Source: Prostate Cancer and Prostatic Diseases - January 21, 2019 Category: Urology & Nephrology Authors: Stephen J. Freedland Lauren Howard Jenifer Allen Jordan Smith Jennifer Stout William Aronson Brant A. Inman Andrew J. Armstrong Daniel George Eric Westman Pao-Hwa Lin Source Type: research

Performance of PCA3 and TMPRSS2:ERG urinary biomarkers in prediction of biopsy outcome in the Canary Prostate Active Surveillance Study (PASS)
Performance of PCA3 and TMPRSS2:ERG urinary biomarkers in prediction of biopsy outcome in the Canary Prostate Active Surveillance Study (PASS), Published online: 21 January 2019; doi:10.1038/s41391-018-0124-zPerformance of PCA3 and TMPRSS2:ERG urinary biomarkers in prediction of biopsy outcome in the Canary Prostate Active Surveillance Study (PASS) (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - January 21, 2019 Category: Urology & Nephrology Authors: Lisa F. Newcomb Yingye Zheng Anna V. Faino Daniella Bianchi-Frias Matthew R. Cooperberg Marshall D. Brown James D. Brooks Atreya Dash Michael D. Fabrizio Martin E. Gleave Michael Liss Todd M. Morgan Ian M. Thompson Andrew A. Wagner Peter R. Carroll Peter Source Type: research

Exploring the risk-reward balance in focal therapy for prostate cancer—a contribution to the debate
Exploring the risk-reward balance in focal therapy for prostate cancer—a contribution to the debateExploring the risk-reward balance in focal therapy for prostate cancer—a contribution to the debate, Published online: 21 January 2019; doi:10.1038/s41391-018-0125-yExploring the risk-reward balance in focal therapy for prostate cancer—a contribution to the debate (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - January 21, 2019 Category: Urology & Nephrology Authors: Anouck Kluytmans Jurgen J. F ütterer Mark Emberton Michiel Sedelaar Janneke Grutters Source Type: research

Prospective examination of the changes in the urinary microbiome induced by transrectal biopsy of the prostate using 16S rRNA gene analysis
Prospective examination of the changes in the urinary microbiome induced by transrectal biopsy of the prostate using 16S rRNA gene analysis, Published online: 21 January 2019; doi:10.1038/s41391-018-0120-3Prospective examination of the changes in the urinary microbiome induced by transrectal biopsy of the prostate using 16S rRNA gene analysis (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - January 21, 2019 Category: Urology & Nephrology Authors: Shaheen Alanee Ahmed El-Zawahry Danuta Dynda Kevin McVary Mallory Karr Andrea Braundmeier-Fleming Source Type: research

Response to Misrai et al.
Response to Misrai et al., Published online: 17 January 2019; doi:10.1038/s41391-018-0122-1Response to Misrai et al. (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - January 17, 2019 Category: Urology & Nephrology Authors: Donald L. Bliwise Source Type: research

Approaches to urinary detection of prostate cancer
Approaches to urinary detection of prostate cancer, Published online: 17 January 2019; doi:10.1038/s41391-019-0127-4Approaches to urinary detection of prostate cancer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - January 17, 2019 Category: Urology & Nephrology Authors: Jillian N. Eskra Daniel Rabizadeh Christian P. Pavlovich William J. Catalona Jun Luo Source Type: research

The anticancer potential of metformin on prostate cancer
The anticancer potential of metformin on prostate cancer, Published online: 16 January 2019; doi:10.1038/s41391-018-0085-2The anticancer potential of metformin on prostate cancer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - January 16, 2019 Category: Urology & Nephrology Authors: Saher Zaidi Jason Gandhi Gunjan Joshi Noel L. Smith Sardar Ali Khan Source Type: research

Impact of new systemic therapies on overall survival of patients with metastatic castration-resistant prostate cancer in a hospital-based registry
Impact of new systemic therapies on overall survival of patients with metastatic castration-resistant prostate cancer in a hospital-based registry, Published online: 14 January 2019; doi:10.1038/s41391-018-0121-2Impact of new systemic therapies on overall survival of patients with metastatic castration-resistant prostate cancer in a hospital-based registry (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - January 14, 2019 Category: Urology & Nephrology Authors: Edoardo Francini Kathryn P. Gray Grace K. Shaw Carolyn P. Evan Anis A. Hamid Caitlin E. Perry Philip W. Kantoff Mary-Ellen Taplin Christopher J. Sweeney Source Type: research

Increased frequency of germline BRCA2 mutations associates with prostate cancer metastasis in a racially diverse patient population
Increased frequency of germline BRCA2 mutations associates with prostate cancer metastasis in a racially diverse patient population, Published online: 12 December 2018; doi:10.1038/s41391-018-0114-1Increased frequency of germline BRCA2 mutations associates with prostate cancer metastasis in a racially diverse patient population (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - December 12, 2018 Category: Urology & Nephrology Authors: Gyorgy Petrovics Douglas K. Price Hong Lou Yongmei Chen Lisa Garland Sara Bass Kristine Jones Indu Kohaar Amina Ali Lakshmi Ravindranath Denise Young Jennifer Cullen Tiffany H. Dorsey Isabell A. Sesterhenn Stephen A. Brassell Inger L. Rosner Doug Ross Wil Source Type: research

Validation of the Decipher Test for predicting adverse pathology in candidates for prostate cancer active surveillance
Validation of the Decipher Test for predicting adverse pathology in candidates for prostate cancer active surveillance, Published online: 12 December 2018; doi:10.1038/s41391-018-0101-6Validation of the Decipher Test for predicting adverse pathology in candidates for prostate cancer active surveillance (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - December 12, 2018 Category: Urology & Nephrology Authors: Hyung L. Kim Ping Li Huei-Chung Huang Samineh Deheshi Tara Marti Beatrice Knudsen Hatem Abou-Ouf Ridwan Alam Tamara L. Lotan Lucia L. C. Lam Marguerite du Plessis Elai Davicioni Neil Fleshner Brian R. Lane Ashley E. Ross John W. Davis James L. Mohler Bruc Source Type: research

Prostatic Urethral Lift (PUL) for obstructive median lobes: 12 month results of the MedLift Study
Prostatic Urethral Lift (PUL) for obstructive median lobes: 12 month results of the MedLift Study, Published online: 12 December 2018; doi:10.1038/s41391-018-0118-xProstatic Urethral Lift (PUL) for obstructive median lobes: 12 month results of the MedLift Study (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - December 12, 2018 Category: Urology & Nephrology Authors: Daniel Rukstalis Douglas Grier Sean Stroup Ronald Tutrone Euclid deSouza Sheldon Freedman Richard David Jed Kamientsky Gregg Eure Source Type: research

Prostate cancer and prostatic diseases Best of China, 2018
Prostate cancer and prostatic diseases Best of China, 2018, Published online: 05 December 2018; doi:10.1038/s41391-018-0117-yProstate cancer and prostatic diseases Best of China, 2018 (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - December 5, 2018 Category: Urology & Nephrology Authors: Ding-Wei Ye Yao Zhu Source Type: research

Preoperative staging using magnetic resonance imaging and risk of positive surgical margins after prostate-cancer surgery
Preoperative staging using magnetic resonance imaging and risk of positive surgical margins after prostate-cancer surgery, Published online: 30 November 2018; doi:10.1038/s41391-018-0116-zPreoperative staging using magnetic resonance imaging and risk of positive surgical margins after prostate-cancer surgery (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 30, 2018 Category: Urology & Nephrology Authors: Fredrik J äderling Olof Akre Markus Aly Johan Bj örklund Mats Olsson Christofer Adding Michael Öberg Lennart Blomqvist Tommy Nyberg Peter Wiklund Stefan Carlsson Source Type: research

Relationship between nocturia and mortality: are we missing the forest for the trees?
Relationship between nocturia and mortality: are we missing the forest for the trees?, Published online: 28 November 2018; doi:10.1038/s41391-018-0115-0Relationship between nocturia and mortality: are we missing the forest for the trees? (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 28, 2018 Category: Urology & Nephrology Authors: Vincent Misra ï Benoit Peyronnet Helene Charbonneau David Attias Atul Pathak Source Type: research

Effect of early salvage radiotherapy at PSA < 0.5 ng/ml and impact of post-SRT PSA nadir in post-prostatectomy recurrent prostate cancer
Effect of early salvage radiotherapy at PSA 
Source: Prostate Cancer and Prostatic Diseases - November 28, 2018 Category: Urology & Nephrology Authors: Dirk Bottke Detlef Bartkowiak Alessandra Siegmann Reinhard Thamm Dirk B öhmer Volker Budach Thomas Wiegel Source Type: research

Role of multiparametric magnetic resonance imaging for patients under active surveillance for prostate cancer: a systematic review with diagnostic meta-analysis
Role of multiparametric magnetic resonance imaging for patients under active surveillance for prostate cancer: a systematic review with diagnostic meta-analysis, Published online: 28 November 2018; doi:10.1038/s41391-018-0113-2Role of multiparametric magnetic resonance imaging for patients under active surveillance for prostate cancer: a systematic review with diagnostic meta-analysis (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 28, 2018 Category: Urology & Nephrology Authors: Francesco Cantiello Giorgio Ivan Russo Sascha Kaufmann Giovanni Cacciamani Fabio Crocerossa Matteo Ferro Ottavio De Cobelli Walter Artibani Sebastiano Cimino Giuseppe Morgia Rocco Damiano Konstantin Nikolaou Nils Kr öger Arnulf Stenzl Jens Bedke Stephan Source Type: research

The role of Prostate Imaging Reporting and Data System score in Gleason 3 + 3 active surveillance candidates enrollment: a diagnostic meta-analysis
The role of Prostate Imaging Reporting and Data System score in Gleason 3 + 3 active surveillance candidates enrollment: a diagnostic meta-analysisThe role of Prostate Imaging Reporting and Data System score in Gleason 3 + 3 active surveillance candidates enrollment: a diagnostic meta-analysis, Published online: 14 November 2018; doi:10.1038/s41391-018-0111-4The role of Prostate Imaging Reporting and Data System score in Gleason 3 + 3 active surveillance candidates enrollment: a diagnostic meta-analysis (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 14, 2018 Category: Urology & Nephrology Authors: Lingyun Zhai Yu Fan Yisen Meng Xueru Feng Wei Yu Jie Jin Source Type: research

Immediate treatment vs. active-surveillance in very-low-risk prostate cancer: the role of patient-, tumour-, and hospital-related factors
Immediate treatment vs. active-surveillance in very-low-risk prostate cancer: the role of patient-, tumour-, and hospital-related factors, Published online: 14 November 2018; doi:10.1038/s41391-018-0109-yImmediate treatment vs. active-surveillance in very-low-risk prostate cancer: the role of patient-, tumour-, and hospital-related factors (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 14, 2018 Category: Urology & Nephrology Authors: Hanneke Jansen Inge M. van Oort George van Andel Bart P. Wijsman Floris J. Pos Maarten C. C. M. Hulshof Christina A. Hulsbergen-van de Kaa Geert J. L. H. van Leenders Jurgen.J. F ütterer Diederink M. Somford Martijn B. Busstra Reindert J. A. van Moorsela Source Type: research

Comparison of biparametric MRI to full multiparametric MRI for detection of clinically significant prostate cancer
Comparison of biparametric MRI to full multiparametric MRI for detection of clinically significant prostate cancer, Published online: 09 November 2018; doi:10.1038/s41391-018-0107-0Comparison of biparametric MRI to full multiparametric MRI for detection of clinically significant prostate cancer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 9, 2018 Category: Urology & Nephrology Authors: Rachael L. Sherrer Zachary A. Glaser Jennifer B. Gordetsky Jeffrey W. Nix Kristin K. Porter Soroush Rais-Bahrami Source Type: research

Circulating tumor DNA in advanced prostate cancer: transitioning from discovery to a clinically implemented test
Circulating tumor DNA in advanced prostate cancer: transitioning from discovery to a clinically implemented test, Published online: 09 November 2018; doi:10.1038/s41391-018-0098-xCirculating tumor DNA in advanced prostate cancer: transitioning from discovery to a clinically implemented test (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 9, 2018 Category: Urology & Nephrology Authors: Enrique Gonz ález-Billalabeitia Vincenza Conteduca Daniel Wetterskog Anuradha Jayaram Gerhardt Attard Source Type: research

Quantification of bone flare on 18F-NaF PET/CT in metastatic castration-resistant prostate cancer
Quantification of bone flare on 18F-NaF PET/CT in metastatic castration-resistant prostate cancer, Published online: 09 November 2018; doi:10.1038/s41391-018-0110-5Quantification of bone flare on 18F-NaF PET/CT in metastatic castration-resistant prostate cancer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 9, 2018 Category: Urology & Nephrology Authors: Amy J. Weisman Stephanie A. Harmon Timothy G. Perk Jens Eickhoff Peter L. Choyke Karen A. Kurdziel William L. Dahut John L. Humm Andrea B. Apolo Steven M. Larson Michael J. Morris Scott B. Perlman Glenn Liu Robert Jeraj Source Type: research